Short Bowel Syndrome clinical trials at UCSF
1 research study open to eligible people
Short bowel syndrome is a condition where the intestines are too short to absorb nutrients well. UCSF is testing the Eclipse XL1 System to safely increase intestinal length in patients. This trial involves both pediatric and adult participants to evaluate its effectiveness.
Showing trials for
Feasibility Study to Evaluate Safety and Probable Benefit of the Eclipse XL1 System for Distraction Enterogenesis in Adult and Pediatric Patients With Short Bowel Syndrome
open to eligible people ages 3 months to 65 years
A Feasibility Study to Evaluate Safety and Probable Benefit of the Eclipse XL1 System for Distraction Enterogenesis in Adult and Pediatric Patients with Short Bowel Syndrome
San Francisco, California and other locations
Our lead scientists for Short Bowel Syndrome research studies include Matthew Lin, MD.
Last updated: